Sveriges Riksbank
RESULT OF RIKSBANK AUCTIONS GOVERNMENT BONDS
RESULT OF RIKSBANK AUCTIONS GOVERNMENT BONDS
Auction date | 2025-05-30 |
Loan | 1061 |
Coupon | 0.75 % |
ISIN-code | SE0011281922 |
Maturity | 2029-11-12 |
Tendered volume, SEK mln | 1500 +/- 1500 |
Total bid volume, SEK mln | 6,225 |
Volume sold, SEK mln | 1,500 |
Number of bids | 15 |
Number of accepted bids | 1 |
Average yield | 1.977 % |
Lowest yield | 1.977 % |
Highest accepted yield | 1.977 % |
% accepted at highest yield | 100.00 |
Auction date | 2025-05-30 |
Loan | 1056 |
Coupon | 2.25 % |
ISIN-code | SE0004517290 |
Maturity | 2032-06-01 |
Tendered volume, SEK mln | 1200 +/- 1200 |
Total bid volume, SEK mln | 4,325 |
Volume sold, SEK mln | 1,200 |
Number of bids | 15 |
Number of accepted bids | 3 |
Average yield | 2.143 % |
Lowest yield | 2.140 % |
Highest accepted yield | 2.145 % |
% accepted at highest yield | 100.00 |
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Novartis Pharma AG1.6.2025 15:00:00 CEST | Press release
Novartis Kisqali® reduces risk of recurrence in younger patients with early breast cancer in NATALEE subgroup analysis
Gatorade31.5.2025 17:39:49 CEST | Press release
Gatorade 5v5 Finals Bring Global Youth to Champions League Stage in Munich
F. Hoffmann-La Roche Ltd31.5.2025 14:05:00 CEST | Press release
New data show Roche’s Itovebi significantly extended survival in a certain type of HR-positive advanced breast cancer
Ipsen Pharma31.5.2025 14:00:00 CEST | Press release
Late-breaking analysis demonstrates characteristics associated with long-term overall survival with Onivyde® regimen in metastatic pancreatic adenocarcinoma
WithSecure Oyj31.5.2025 08:45:00 CEST | Press release
WithSecure has completed the transaction of Cyber security consulting divestment to Neqst
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom